作者:Patrick Hochegger、Johanna Faist、Werner Seebacher、Robert Saf、Pascal Mäser、Marcel Kaiser、Robert Weis
DOI:10.1016/j.bmc.2017.02.043
日期:2017.4
New analogues of the recently published compound DDD107498 were prepared. Their activities were examined in vitro against the chloroquine-sensitive NF54 strain. The most active were also tested against the multiresistant K1 strain of Plasmodium falciparum. A couple of the newly synthesized compounds showed promising antiplasmodial activity and selectivity. A single compound showed adequate reduction
制备了最近公开的化合物DDD107498的新类似物。在体外检查了它们对氯喹敏感的NF54菌株的活性。还测试了最具活性的抗恶性疟原虫的K1菌株。几个新合成的化合物显示出有希望的抗血浆活性和选择性。单一化合物在感染了伯氏疟原虫的小鼠中显示出足够的寄生虫血症降低率(98.1%)。与对照相比,存活时间增加了一倍。将新化合物的生物学测试结果与所用药物的活性进行了比较。讨论了构效关系。